Sotiriou C - Search Results

1

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.

Fumagalli D, Wilson TR, Salgado R, Lu X, Yu J, O'Brien C, Walter K, Huw LY, Criscitiello C, Laios I, Jose V, Brown DN, Rothé F, Maetens M, Zardavas D, Savas P, Larsimont D, Piccart-Gebhart MJ, Michiels S, Lackner MR, Sotiriou C, Loi S. Fumagalli D, et al. Among authors: sotiriou c. Ann Oncol. 2016 Oct;27(10):1860-6. doi: 10.1093/annonc/mdw286. Ann Oncol. 2016. PMID: 27672107 Free article.

2

Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases.

Sotiriou C, Lacroix M, Lespagnard L, Larsimont D, Paesmans M, Body JJ. Sotiriou C, et al. Cancer Lett. 2001 Aug 10;169(1):87-95. doi: 10.1016/s0304-3835(01)00524-9. Cancer Lett. 2001. PMID: 11410329

3

Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002.

Di Leo A, Cardoso F, Durbecq V, Giuliani R, Mano M, Atalay G, Larsimont D, Sotiriou C, Biganzoli L, Piccart MJ. Di Leo A, et al. Among authors: sotiriou c. Int J Clin Oncol. 2002 Aug;7(4):245-53. doi: 10.1007/s101470200036. Int J Clin Oncol. 2002. PMID: 12202978 Review.

4

Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatment.

Seo HS, Journé F, Larsimont D, Sotiriou C, Leclercq G. Seo HS, et al. Among authors: sotiriou c. Steroids. 2003 Mar;68(3):257-69. doi: 10.1016/s0039-128x(02)00179-4. Steroids. 2003. PMID: 12628689

5

Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-alpha gene amplification and protein overexpression in locally advanced/metastatic breast cancer.

Cardoso F, Durbecq V, Larsimont D, Paesmans M, Leroy JY, Rouas G, Sotiriou C, Renard N, Richard V, Piccart MJ, Di Leo A. Cardoso F, et al. Among authors: sotiriou c. Int J Oncol. 2004 Jan;24(1):201-9. Int J Oncol. 2004. PMID: 14654958

6

Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancer.

Durbecq V, Desmed C, Paesmans M, Cardoso F, Di Leo A, Mano M, Rouas G, Leroy JY, Sotiriou C, Piccart M, Larsimont D. Durbecq V, et al. Among authors: sotiriou c. Int J Oncol. 2004 Nov;25(5):1473-9. doi: 10.3892/ijo.25.5.1473. Int J Oncol. 2004. PMID: 15492841

7

Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancer.

Cardoso F, Paesmans M, Larsimont D, Durbecq V, Bernard-Marty C, Rouas G, Dolci S, Sotiriou C, Piccart MJ, Di Leo A. Cardoso F, et al. Among authors: sotiriou c. Clin Breast Cancer. 2004 Dec;5(5):364-9. doi: 10.3816/cbc.2004.n.043. Clin Breast Cancer. 2004. PMID: 15585074

8

Challenges in breast cancer clinical trial design in the postgenomic era.

Loi S, Buyse M, Sotiriou C, Cardoso F. Loi S, et al. Among authors: sotiriou c. Curr Opin Oncol. 2004 Nov;16(6):536-41. doi: 10.1097/01.cco.0000142925.99075.a0. Curr Opin Oncol. 2004. PMID: 15627014 Review.

9

Breast cancer gene expression profiling: clinical trial and practice implications.

Loi S, Desmedt C, Cardoso F, Piccart M, Sotiriou C. Loi S, et al. Among authors: sotiriou c. Pharmacogenomics. 2005 Jan;6(1):49-58. doi: 10.1517/14622416.6.1.49. Pharmacogenomics. 2005. PMID: 15723605 Review.

10

Bringing molecular prognosis and prediction to the clinic.

Colozza M, Cardoso F, Sotiriou C, Larsimont D, Piccart MJ. Colozza M, et al. Among authors: sotiriou c. Clin Breast Cancer. 2005 Apr;6(1):61-76. doi: 10.3816/CBC.2005.n.010. Clin Breast Cancer. 2005. PMID: 15899074 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters